International Marijuana Business News

Thailand’s justice minister continues push to delist marijuana

Thailand’s Justice Minister Paiboon Koomchaya has reiterated his stance to reclassify marijuana from a narcotic drug to a medicinal herb. The official says the government has failed to police marijuana, as well as stimulant kratom, so both plants should be treated as herbs, according to the Bangkok Post. The justice minister has said that prohibition isn’t […]

Read More

Denmark embarks on limited MMJ program but will import cannabis

Beginning in 2018, medical cannabis will be legal in Denmark for 1,500 patients who suffer from chronic diseases. But the Danish government currently plans to import the cannabis from state-run producers in the Netherlands, Business Insider Nordic reported. That isn’t going over well with some Danish farmers, who are lobbying their government to allow them to […]

Read More

Another Canadian medical marijuana firm licensed to export

Aphria, a federally licensed medical marijuana cultivator in Canada, has been chosen to export product to Australian biotech company Medlab Clinical. Medlab Clinical is conducting trials on the use of cannabis to manage pain in cancer patients, according to the Australian Associated Press, and will import a liquid blend of THC and CBD from Aphria […]

Read More

Australia’s MMJ market likely to develop slowly, with big players dominating

By Bart Schaneman Cannabis entrepreneurs hoping to enter Australia’s new medical marijuana market will confront obstacles at the federal and state level, with industry observers predicting a limited number of big companies will come to dominate the business. Australia’s MMJ market also is expected to develop slowly, given complex licensing procedures and strict, costly regulations.

Read More

Australian CBD producer to distribute in Czech Republic

Talk about an international operation. An Australian nutraceutical company that manufactures hemp-based CBD products in Switzerland is planning to sell them in the Czech Republic, according to a news release from the company, Creso Pharma. Creso, a public company that trades on the Australian stock exchange, said it has signed a distribution agreement with the […]

Read More

Australian entrepreneurs can now apply to grow medical cannabis

Australian cannabis business owners can now apply for licenses to grow medical marijuana under the country’s new MMJ law. The Australian government’s Narcotics Drug Amendment Act 2016 took effect on Oct. 30, according to Australia Network News. It allows businesses to grow marijuana for medicine, conduct research on the plant and create marijuana products for medicinal purposes. […]

Read More

British Sugar to grow cannabis for GW Pharma

GW Pharmaceuticals, the British developer of a CBD-based anti-seizure medicine that could be on American shelves in 2018, has contracted Britain’s leading sugar supplier to grow its medical cannabis. British Sugar, the top beet sugar supplier in the UK, will grow the cannabis in an 18-hectare greenhouse in eastern England, where the company now grows tomatoes, […]

Read More

Israeli pharmacies to start selling medical cannabis

Israeli pharmacies are gearing up to sell medical marijuana across the nation under the government’s ongoing efforts to liberalize the use and sale of MMJ. Super-Pharm, which has 225 branches across Israel, has been consulting with the nation’s health ministry to allow prescription and provision of medical marijuana by authorized doctors and pharmacists, Israel’s Haaretz […]

Read More

Australian MMJ company lists stock, which soars

An Australian developer of marijuana-based medicines that debuted on the Australian Securities Exchange Thursday saw its stock soar 38% above its offering price before settling in to close 30% above its listing price. The Sydney Morning Herald valued Creso Pharma at about $11.5 million Australian dollars (about $9.7 million). The company (CPH AX) listed on the ASX […]

Read More

GW Pharma scuttles UK listing to trade on U.S. market

GW Pharmaceuticals, a high-flying biotech firm in the United Kingdom that is seeking U.S. regulatory approval for a CBD-based drug, has abandoned its U.K. stock market listing to instead trade exclusively in the United States. The firm announced it would ditch its Aim market listing this December, according to Britain’s Telegraph newspaper. A company executive […]

Read More

Turkey to allow limited MMJ production

The Turkish government has legalized medical cannabis production in 19 of its 81 provinces, but the step forward is quite tentative and has a lot of strings attached. According to Britain’s Independent newspaper, the move by the Ministry of Food, Agriculture and Livestock is intended to combat the black market. But many specifics are unclear. For […]

Read More